Validity of self-reports of return for routine repeat screening in an ovarian cancer screening program.
Cancer screening research relies on reliable and valid measurement of cancer screening behavior. Self-reports of screening constitute a cost-effective approach to measuring screening behavior; however, demonstration of suitable validity of these self-reports is critical. We evaluated the validity of self-report of return for repeat, routine, annual transvaginal sonography (TVS) screening for ovarian cancer. Participants (n = 535) in a university-based ovarian cancer screening program for asymptomatic, average risk women completed a telephone interview 18 months following an initial, baseline TVS screening test. Self-reports of return for a repeat, routine ovarian cancer screening test since baseline were obtained and compared with objective records of repeat screening from the screening program database. Overall agreement of self-reports and objective records of ovarian cancer screening was 97.57% (kappa = 0.94). Sensitivity was 0.98, specificity was 0.96, positive predictive value was 0.98, and negative predictive value was 0.96. The month of last screening was accurately identified by 80% of participants. It was concluded the validity of self-reports of TVS screening for ovarian cancer is very high and may even exceed the validity of self-reports of participation in breast, cervical, and colorectal cancer screening over similar recall periods. Consequently, self-reports of TVS screening may serve as a cost-effective substitute for more objective methods of assessing TVS screening behavior.
Lykins
Emily L B
EL
Department of Behavioral Science, University of Kentucky College of Medicine, Lexington, KY 40536-0086, USA.
Pavlik
Edward L
EL
Andrykowski
Michael A
MA
D005260:Female; D006801:Humans; D007407:Interviews as Topic; D007629:Kentucky; D008403:Mass Screening / Q000523:psychology*; D008875:Middle Aged; D015999:Multivariate Analysis; D010051:Ovarian Neoplasms / Q000000981:diagnostic imaging* / Q000523:psychology*; D010349:Patient Compliance; D011237:Predictive Value of Tests; D012650:Self Disclosure; D012680:Sensitivity and Specificity; D014463:Ultrasonography